Related Experiment Video
Updated: Feb 28, 2026

Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells
Published on: September 1, 2019
Small-nucleolar RNA host gene3 (SNHG3) and leukemia-associated non-coding IGF1R activator RNA 1 (LUNAR1) correlated
Omnia Emam1, Eman F Wasfey2, Mostafa Elnakib3,4
1Egyptian Drug Authority, Cairo, Egypt.
Abstract:
Notch-signaling is implicated in tumorigenesis as well as Notch-associated long non-coding RNAs (lncRNAs) small nucleolar RNA host gene3 (SNHG3) and leukemia-associated non-coding IGF1R activator RNA 1 (LUNAR1) are highly expressed in various malignant tissues including colorectal cancer (CRC). However, the clinical and prognostic utility of these lncRNAs in CRC patients' blood is still lacking. The aim of this study was to assess the expression patterns of circulatory Notch-associated lncRNAs SNHG3 and LUNAR1 and to explore their relevance for CRC follow up and risk assessment.
Subject And Methods:
Quantitative real-time polymerase chain reaction (qRT-PCR) was used to quantify the expression levels of SNHG3 and LUNAR1 in sera of 70 Egyptian CRC patients' and to compare them with 26 age- and sex-matched apparently healthy volunteer control group.
Results:
Serum fold-change expression of SNHG3 and LUNAR1 were up-regulated in CRC patients compared to the apparently healthy controls (p < 0.0001). SNHG3 lncRNA fold expression levels were positively correlated with advanced CRC stage (III-IV) (p = 0.0175) being highly related to poorer clinicopathological features of CRC patients including extensive tumor invasion (p = 0.0046), vascular invasion (p = 0.0015), and lymph node metastasis (p = 0.0175). Likewise, LUNAR1 lncRNA fold-expression level was significantly positively associated with larger tumor size (p = 0.0033) and deeper tumor invasion (p = 0.042). The two lncRNAs had higher discriminative utility than either CEA or CA19-9 per the receiver operating characteristic (ROC) curve, with higher sensitivities and specificities (p < 0.0001). A significant positive correlation between SNHG3 and LUNAR1 lncRNAs fold expressions (r = 0.4615, p < 0.0001).
Conclusion:
SNHG3 and LUNAR1 might be useful non-invasive bio-molecular markers for CRC monitoring. Being correlated with poorer CRC patients' clinical features, SNHG3 and LUNAR1 lncRNAs might constitute potential putative therapeutic targets for CRC, per identified downstream genes or proteins in silico, a step toward ncRNA-based precision medicine.
Insights
Circulating Notch-associated long non-coding RNAs (lncRNAs), SNHG3 and LUNAR1, are elevated in colorectal cancer (CRC) patients. These lncRNAs show potential as non-invasive biomarkers for CRC monitoring and risk assessment.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Notch-signaling is involved in tumorigenesis.
- Notch-associated long non-coding RNAs (lncRNAs), SNHG3 and LUNAR1, are upregulated in various cancers, including colorectal cancer (CRC).
- The clinical and prognostic value of these circulatory lncRNAs in CRC remains underexplored.
Purpose of the Study:
- To assess the expression patterns of circulatory SNHG3 and LUNAR1 in CRC patients.
- To investigate the relevance of these lncRNAs for CRC follow-up and risk stratification.
- To evaluate their potential as non-invasive biomarkers for CRC.
Main Methods:
- Quantitative real-time polymerase chain reaction (qRT-PCR) was employed to measure SNHG3 and LUNAR1 expression levels.
- Serum samples from 70 Egyptian CRC patients and 26 healthy controls were analyzed.
- Statistical analyses were performed to compare expression levels and correlate them with clinicopathological features.
Main Results:
- Serum SNHG3 and LUNAR1 were significantly upregulated in CRC patients compared to controls (p < 0.0001).
- SNHG3 expression correlated positively with advanced CRC stage, tumor invasion, vascular invasion, and lymph node metastasis.
- LUNAR1 expression was associated with larger tumor size and deeper invasion. Both lncRNAs demonstrated higher diagnostic accuracy than CEA and CA19-9.
Conclusions:
- Circulatory SNHG3 and LUNAR1 serve as promising non-invasive biomarkers for CRC monitoring.
- These lncRNAs correlate with adverse clinicopathological features, suggesting their potential as prognostic indicators.
- SNHG3 and LUNAR1 may represent novel therapeutic targets for CRC, paving the way for ncRNA-based precision medicine.
More Related Videos
13:21Comprehensive DNA Methylation Analysis Using a Methyl-CpG-binding Domain Capture-based Method in Chronic Lymphocytic Leukemia Patients
Published on: June 16, 2017
09:02Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
Published on: November 26, 2018
Related Concept Videos
lncRNA - Long Non-coding RNAs
Non-LTR Retrotransposons
The Nucleolus
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...